Percutaneous Transparaumbilical Embolization of Spontaneous Portosystemic Shunts for the Treatment of Hepatic Encephalopathy

J Vasc Interv Radiol. 2017 Nov;28(11):1563-1568. doi: 10.1016/j.jvir.2017.04.028.

Abstract

The medical records of 7 patients who underwent percutaneous transparaumbilical embolization of spontaneous portosystemic shunts for treatment of hepatic encephalopathy (HE) were retrospectively reviewed. Technical success was achieved in 100% (7/7) of patients. Four patients had complete resolution and 3 had improvement of signs and symptoms of HE within 3 days after the procedure for a clinical success rate of 100% (7/7). New-onset esophageal varices, a major complication, occurred in 1 patient. No other major complications were encountered. HE recurred in 71.4% (5/7) of patients during a median follow-up period of 43 months (range, 4-111 months).

MeSH terms

  • Aged
  • Angiography, Digital Subtraction
  • Embolization, Therapeutic / methods*
  • Female
  • Hepatic Encephalopathy / diagnostic imaging*
  • Hepatic Encephalopathy / therapy*
  • Humans
  • Liver Circulation
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome
  • Umbilicus*